Pediatric Renal Transplantation

Transplantation is the preferred method of treatment for end-stage renal disease in children. The rate ofpediatric kidney transplantation has been steadily rising over the past decade. The use of increasingly potent immunosuppressive drugs has lessened the risk for acute rejection substantially and improved short-term outcomes; however, the long-term outcomes have remained inadequate
Renal transplantation is the treatment of choice for pediatric patients with end-stage renal failure. Living donor transplantation (LDT) has become an important therapeutic option due to the shortage of cadaver donors and increasingly long waiting times. In a living-donor transplant, an adult (18 or older) gives one kidney to the child. The donor can be either a family member or someone unrelated, such as an adult family friend. The potential donor will first undergo a series of tests to measure compatibility.
Kidney transplantation involves more than simply an operation. Human leukocyte antigens (HLA) and panel reactive antibody (PRA)

    Related Conference of Pediatric Renal Transplantation

    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    October 05-06, 2026

    39th World Pediatrics Conference

    Madrid, Spain
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE
    December 03-04, 2026

    11th Annual Pediatric Congress

    Madrid, Spain
    December 29-30, 2026

    35th World Congress on Clinical Pediatrics

    Edinburgh, Scotland

    Pediatric Renal Transplantation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in